Inhibition of Neuroinflammation in LPS-Activated Microglia by Cryptolepine
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Cryptolepine, an indoloquinoline alkaloid in Cryptolepis sanguinolenta, has anti-inflammatory property. In this study, we aimed to evaluate the effects of cryptolepine on lipopolysaccharide (LPS)- induced neuroinflammation in rat microglia and its potential mechanisms. Microglial activation was induced by stimulation with LPS, and the effects of cryptolepine pretreatment on microglial activation and production of proinflammatory mediators, PGE 2/COX-2, microsomal prostaglandin E 2 synthase and nitric oxide/iNOS were investigated. We further elucidated the role of Nuclear Factor-kappa B (NF-κ B) and the mitogen-activated protein kinases in the antiinflammatory actions of cryptolepine in LPS-stimulated microglia. Our results showed that cryptolepine significantly inhibited LPS-induced production of tumour necrosis factor-alpha (TNF α), interleukin-6 (IL-6), interleukin-1beta (IL-1 β), nitric oxide, and PGE 2. Protein and mRNA levels of COX-2 and iNOS were also attenuated by cryptolepine. Further experiments on intracellular signalling mechanisms show that I κ B-independent inhibition of NF-κ B nuclear translocation contributes to the anti-neuroinflammatory actions of cryptolepine. Results also show that cryptolepine inhibited LPS-induced p38 and MAPKAPK2 phosphorylation in the microglia. Cell viability experiments revealed that cryptolepine (2.5 and 5 μ M) did not produce cytotoxicity in microglia. Taken together, our results suggest that cryptolepine inhibits LPS-induced microglial inflammation by partial targeting of NF-κ B signalling and attenuation of p38/MAPKAPK2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727 · cited 1×
“In particular, NF-κB is an important upstream regulator of cytokine, COX-2, and iNOS expressions [28].”
BackgroundMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557 · cited 1×
“Neuroinflammation is a process which principally involves activation of astrocytes andmicroglia by inflammatorymediators in various CNS pathologies, including brain inflammation, trauma, ischemia, stroke, brain infections, and neurodegenerative CNS disorders [1, 2], such as multiple sclerosis (MS), Alzheimer’s disease…”
BackgroundDoes neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells
Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., & Hao, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.033 · Cited by 221 · cited 1×
“LPS and other inflammatory stimuli have been reported to activate the MAPK and NF-κB signalling pathways in microglia [27].”
BackgroundAcetate reduces microglia inflammatory signaling in vitro
Soliman, M. L., Puig, K. L., Combs, C. K., & Rosenberger, T. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07955.x · Cited by 131 · cited 1×
“Mitogen-activated protein kinases (MAPK) are critical regulators of pro-inflammatory cytokines (TNFα, IL-6 and IL-1β) during inflammation [8].”
Background
Cited by
Cascade of immune mechanism and consequences of inflammatory disorders
Megha, K., Joseph, X., Akhil, V., & Mohanan, P. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153712 · Cited by 355
Neuroprotective Natural Products for Alzheimer’s Disease
Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236
Microglia increase inflammatory responses in iPSC-derived human BrainSpheres
Abreu, C. M., Gama, L., Krasemann, S., Chesnut, M., Odwin-Dacosta, S., Hogberg, H. T., Hartung, T., & Pamies, D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02766 · Cited by 123
Zheng, Y., Zhang, X., Zhang, R., Wang, Z., Gan, J., Gao, Q., Yang, L., Xu, P., & Jiang, X. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5314 · Cited by 52
“…the research and design of innovative anti‑inflammatory drugs. cryptolepine, an indoloquinoline alkaloid isolated from Cryptolepis sanguinolenta , has demonstrated the ability to suppress LPS‑induced microglia inflammation by selectively targeting the NF‑ κ B and p38 MAPK signaling pathways (157).”
Background
Metadata
- Authors
- Olajide, O. A., Bhatia, H. S., de Oliveira, A. C. P., Wright, C. W., & Fiebich, B. L.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-10
- ISSN
- 1741-427X (ISSN-L)
- 1741-4288
- OpenAlex
- W2093248671
- Cited by
- 70
- References
- 6
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Neuroinflammation in LPS-Activated Microglia by Cryptolepine. https://app.cochat.ai/papers/10.1155/2013/459723
- The paper
- Olajide, O. A., Bhatia, H. S., de Oliveira, A. C. P., Wright, C. W., & Fiebich, B. L. (2013). Inhibition of Neuroinflammation in LPS-Activated Microglia by Cryptolepine. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2013/459723
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.